Pad Printing Cliché Geometry for Volatile TTS Drug Transfer
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing pad printing methods struggle to reliably produce transdermal therapeutic systems (TTS) containing volatile active agents like nicotine or linalool without using absorbent substrates like paper or cotton fleece, leading to production inefficiencies and instability due to air inclusions and oxidation sensitivity.
Innovation Solution
Adjusting the geometry of the printing cliché by making the indentation area larger than the active-agent-containing imprint, ensuring complete transfer of the active agent onto a non-absorbent substrate such as a pressure-sensitive adhesive.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If the indentation area of the cliché is made equal to the imprint area for complete active agent transfer, then manufacturing precision is improved, but the risk of overflow and production downtime increases
Solution Approach 1:
The cliché indentation area is segmented into two functional zones: a larger overflow prevention area that contains excess active agent, and a smaller precise transfer area that contacts the substrate. This segmentation allows the system to simultaneously achieve complete transfer (by having sufficient agent in the larger area) and prevent overflow (by limiting the contact area to only what is needed).
Solution Approach 2:
Different areas of the cliché indentation are given different functional qualities: the central region that contacts the substrate provides precise transfer, while the peripheral region contains excess agent to prevent overflow. This local differentiation of function resolves the contradiction between complete transfer and overflow prevention.
2Quantity of substance
If volatile active agents are used in TTS production, then product efficacy is improved, but production losses and vaporisation increase
Solution Approach 1:
The pad printing system acts as an intermediary that transfers active agent in a controlled, enclosed manner. The flexible pad and enclosed cliché structure minimize exposure of volatile agents to air, reducing vaporisation losses while maintaining efficient delivery to the substrate.
Solution Approach 2:
The pad printing process creates a controlled, enclosed environment during transfer that protects volatile active agents from oxidation and vaporisation. The process occurs in a confined space with minimal air contact, effectively creating an inert atmosphere that preserves the active agent.
3Quantity of substance
If absorbent substrates like paper or cotton fleece are used for TTS production, then active agent absorption is improved, but stability decreases due to air inclusions and oxidation
Solution Approach 1:
The invention replaces durable but problematic absorbent substrates (paper, cotton) with a non-absorbent adhesive layer that is applied fresh in each printing cycle. This approach sacrifices substrate reusability (disposable nature) to achieve superior stability by eliminating air inclusions and oxidation risks associated with porous materials.
Solution Approach 2:
The substrate property is changed from absorbent (porous) to non-absorbent (non-porous adhesive layer). This parameter change eliminates the mechanism (porosity) that causes air inclusions and oxidation, thereby improving stability while maintaining active agent delivery through the adhesive's chemical properties rather than physical absorption.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Ensures neat and reliable production of TTS with volatile active agents, avoiding production downtimes and maintaining stability by preventing overflow and oxidation, while adhering to pharmaceutical standards.
Implementation Method 1
an elastic pad made of silicone rubber from the printing plate to the substrate
Implementation Method 2
The print medium layer remaining in the indentation of the cliché is fully received by the pad by pressing this on and is transferred to the object to be printed
Data Source
AI summary
The present invention relates to a pad printing method for producing an administration form for a pharmaceutical active agent, wherein the method comprises providing a substrate of the administration form and transferring the active agent by means of a pad from a cliché onto the substrate, wherein the area of the cliché is larger than the active-agent-containing area printed onto the substrate. This method is especially suitable for producing transdermal therapeutic systems with volatile active agents. The present invention also relates to arrangements by means of which a method of this kind can be implemented.


